BioLineRx Ltd (BLRX) — Cash Flow Quality Index
Latest as of March 2025:
-0.51x
BioLineRx Ltd (BLRX) has a Cash Flow Quality Index of -0.51x as of March 2025. Operating cash flow of $-2.59 Million is below net income of $5.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BLRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.51x
Operating CF / Net Income
Operating Cash Flow
$-2.59 Million
USD
Net Income
$5.13 Million
USD
Data as of
Mar 2025
Most recent filing
BioLineRx Ltd Cash Flow Quality Index (2010–2010)
Historical Cash Flow Quality Index for BioLineRx Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see BioLineRx Ltd cash conversion from operations.
Annual Cash Flow Quality Index for BioLineRx Ltd (2010–2010)
Year-by-year earnings quality comparison for BioLineRx Ltd.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2010 | 5.47x | $11.46 Million | $2.10 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.